drugset / Trial / NCT01132625
Dose Escalation Study of AUY922 in Advanced Solid Malignancies in Japan
Non-randomizedSingle-groupOpen-labelTreatment
Summary
This study will characterize the safety, tolerability, efficacy, pharmacokinetics, and pharmacodynamics of AUY922 in adult patients with advanced solid malignancies in Japan.
Timeline
- Start
- 2008-11
- Primary completion
- 2012-05
- Completion
- 2012-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AUY922 | Small molecule | — | Intravenous |